Literature DB >> 17888644

Toll-like receptors: paving the path to T cell-driven autoimmunity?

Benjamin J Marsland1, Manfred Kopf.   

Abstract

The development of autoimmunity is often associated with the presence of pathogen-associated molecular patterns (PAMPs) and signaling through toll-like receptors (TLRs). Largely, the importance of PAMP-TLR ligation has been attributed to inducing the maturation of antigen-presenting cells and production of proinflammatory cytokines and chemokines. Recent evidence now shows that PAMPs can activate effector and regulatory T cells revealing a further level of complexity in the development of autoimmunity. TLR signaling on T cells acts as a form of costimulation, lowering the 'strength of signal' required for proliferation and survival. This apparent mechanism of immune homeostasis may break tolerance or anergy upon pathogen infection and promote the development of immune responses against self-antigens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888644     DOI: 10.1016/j.coi.2007.07.022

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  10 in total

1.  Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.

Authors:  Mikaela M Tremblay; Mahmood Y Bilal; Jon C D Houtman
Journal:  Mol Immunol       Date:  2013-10-12       Impact factor: 4.407

2.  Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Ana Cristina Wing; Taissa M Kasahara; Priscila M Sacramento; Solange Camargo; Fernanda Rueda; Soniza V Alves-Leon; Regina Alvarenga; Claudia Cristina Vasconcelos; Anshu Agrawal; Sudhir Gupta; Cleonice A M Bento
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

3.  Expression and Function of TLR2 on CD4 Versus CD8 T Cells.

Authors:  Sun-Mi Lee; Young-Don Joo; Su-Kil Seo
Journal:  Immune Netw       Date:  2009-08-31       Impact factor: 6.303

4.  Trace levels of innate immune response modulating impurities (IIRMIs) synergize to break tolerance to therapeutic proteins.

Authors:  Daniela Verthelyi; Vivian Wang
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

5.  Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists.

Authors:  Catherine Gurley; Jessica Nichols; Shuliang Liu; Nirmal K Phulwani; Nilufer Esen; Tammy Kielian
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

6.  Impaired Innate Immunity in Pediatric Patients Type 1 Diabetes-Focus on Toll-like Receptors Expression.

Authors:  Katarzyna Kurianowicz; Maria Klatka; Agnieszka Polak; Anna Hymos; Dominika Bębnowska; Martyna Podgajna; Rafał Hrynkiewicz; Olga Sierawska; Paulina Niedźwiedzka-Rystwej
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

7.  NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells.

Authors:  Blandine C Mercier; Erwan Ventre; Marie-Laure Fogeron; Anne-Laure Debaud; Martine Tomkowiak; Jacqueline Marvel; Nathalie Bonnefoy
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Peter Nemeth; Katalin Mikecz; Tibor T Glant
Journal:  Int Immunol       Date:  2009-03-02       Impact factor: 4.823

9.  Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.

Authors:  Tomohiro Kubo; Yuki Uchida; Yuko Watanabe; Masahiro Abe; Akira Nakamura; Masao Ono; Shizuo Akira; Toshiyuki Takai
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

10.  TNFa alter cholesterol metabolism in human macrophages via PKC-θ-dependent pathway.

Authors:  A Zhi Sha Ma; Qian Zhang; Zhi Yuan Song
Journal:  BMC Biochem       Date:  2013-08-03       Impact factor: 4.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.